{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["brain", "flavonoid", "myricetin", "neuroinflammation", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34975495", "DateRevised": {"Year": "2022", "Month": "01", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "16"}], "Language": ["eng"], "ELocationID": ["797298", "10.3389/fphar.2021.797298"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models.", "Pagination": {"StartPage": "797298", "MedlinePgn": "797298"}, "Abstract": {"AbstractText": ["Myricetin is a natural flavonoid extracted from a variety of plants, such as medicinal herbs, vegetables, berries, and tea leaves. A growing body of evidence has reported that myricetin supplementation display therapeutic activities in a lot of nervous system disorders, such as cerebral ischemia, Alzheimer's disease, Parkinson's disease, epilepsy, and glioblastoma. Myricetin supplementation can also protect against pathological changes and behavioral impairment induced by multiple sclerosis and chronic stress. On the basis of these pharmacological actions, myricetin could be developed as a potential drug for the prevention and/or treatment of nervous system disorders. Mechanistic studies have shown that inhibition of oxidative stress, cellular apoptosis, and neuroinflammatory response are common mechanisms for the neuroprotective actions of myricetin. Other mechanisms, including the activation of the nuclear factor E2-related factor 2 (<i>Nrf2</i>), extracellular signal-regulated kinase 1/2 (ERK1/2), protein kinase B (Akt), cyclic adenosine monophosphate-response element binding protein (CREB), and brain-derived neurotrophic factor (BDNF) signaling, inhibition of intracellular Ca<sup>2+</sup> increase, inhibition of c-Jun N-terminal kinase (JNK)-p38 activation, and suppression of mutant protein aggregation, may also mediate the neuroprotective effects of myricetin. Furthermore, myricetin treatment has been shown to promote the activation of the inhibitory neurons in the hypothalamic paraventricular nucleus, which subsequently produces anti-epilepsy effects. In this review, we make a comprehensive understanding about the pharmacological effects of myricetin in the nervous system, aiming to push the development of myricetin as a novel drug for the treatment of nervous system disorders."], "CopyrightInformation": "Copyright \u00a9 2021 Li, Xiang, Huang and Lu."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gastroenterology, The People's Hospital of Taizhou, The Fifth Affiliated Hospital of Nantong University, Taizhou, China."}], "LastName": "Li", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, China."}], "LastName": "Xiang", "ForeName": "Haitao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Pharmacy, Nantong University, Nantong, China."}], "LastName": "Huang", "ForeName": "Chao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, The People's Hospital of Taizhou, The Fifth Affiliated Hospital of Nantong University, Taizho, China."}], "LastName": "Lu", "ForeName": "Jiashu", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abidov M., Ramazanov A., Jimenez Del Rio M., Chkhikvishvili I. (2006). Effect of Blueberin on Fasting Glucose, C-Reactive Protein and Plasma Aminotransferases, in Female Volunteers with Diabetes Type 2: Double-Blind, Placebo Controlled Clinical Study. Georgian Med. News 141, 66\u201372. 10.1007/s10517-006-0167-3", "ArticleIdList": ["10.1007/s10517-006-0167-3", "17261891"]}, {"Citation": "Ahmed T., Zahid S., Mahboob A., Farhat S. M. (2017). Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease. Curr. Neuropharmacol. 15 (4), 480\u2013494. 10.2174/1570159X14666160325121145", "ArticleIdList": ["10.2174/1570159X14666160325121145", "PMC5543671", "27012953"]}, {"Citation": "Ahrens M. J., Thompson D. L. (2013). Effect of Emulin on Blood Glucose in Type 2 Diabetics. J. Med. Food 16 (3), 211\u2013215. 10.1089/jmf.2012.0069", "ArticleIdList": ["10.1089/jmf.2012.0069", "23444965"]}, {"Citation": "Andjelkovic A. V., Xiang J., Stamatovic S. M., Hua Y., Xi G., Wang M. M., et al. (2019). Endothelial Targets in Stroke: Translating Animal Models to Human. Arterioscler. Thromb. Vasc. Biol. 39 (11), 2240\u20132247. 10.1161/ATVBAHA.119.312816", "ArticleIdList": ["10.1161/ATVBAHA.119.312816", "PMC6812626", "31510792"]}, {"Citation": "Bonif\u00e1cio M. J., Palma P. N., Almeida L., Soares-da-Silva P. (2007). Catechol-O-methyltransferase and its Inhibitors in Parkinson's Disease. CNS Drug Rev. 13 (3), 352\u2013379. 10.1111/j.1527-3458.2007.00020.x", "ArticleIdList": ["10.1111/j.1527-3458.2007.00020.x", "PMC6494163", "17894650"]}, {"Citation": "Boriero D., Carcereri de Prati A., Antonini L., Ragno R., Sohji K., Mariotto S. (2021). The Anti-STAT1 Polyphenol Myricetin Inhibits M1 Microglia Activation and Counteracts Neuronal Death. FEBS J. 288 (7), 2347\u20132359. 10.1111/febs.15577", "ArticleIdList": ["10.1111/febs.15577", "32981207"]}, {"Citation": "Butturini E., Boriero D., Carcereri de Prati A., Mariotto S. (2019). STAT1 Drives M1 Microglia Activation and Neuroinflammation under Hypoxia. Arch. Biochem. Biophys. 669, 22\u201330. 10.1016/j.abb.2019.05.011", "ArticleIdList": ["10.1016/j.abb.2019.05.011", "31121156"]}, {"Citation": "Chang Y., Chang C. Y., Wang S. J., Huang S. K. (2015). Myricetin Inhibits the Release of Glutamate in Rat Cerebrocortical Nerve Terminals. J. Med. Food 18 (5), 516\u2013523. 10.1089/jmf.2014.3219", "ArticleIdList": ["10.1089/jmf.2014.3219", "PMC4410760", "25340625"]}, {"Citation": "Chen S., Chen H., Du Q., Shen J. (2020). Targeting Myeloperoxidase (MPO) Mediated Oxidative Stress and Inflammation for Reducing Brain Ischemia Injury: Potential Application of Natural Compounds. Front. Physiol. 11, 433. 10.3389/fphys.2020.00433", "ArticleIdList": ["10.3389/fphys.2020.00433", "PMC7248223", "32508671"]}, {"Citation": "Ciacciarelli A., Sette G., Giubilei F., Orzi F. (2020). Chronic Cerebral Hypoperfusion: An Undefined, Relevant Entity. J. Clin. Neurosci. 73, 8\u201312. 10.1016/j.jocn.2020.01.026", "ArticleIdList": ["10.1016/j.jocn.2020.01.026", "31948882"]}, {"Citation": "Claudino F. C. A., Gon\u00e7alves L., Schuch F. B., Martins H. R. S., da Rocha N. S. (2020). The Effects of Individual Psychotherapy in BDNF Levels of Patients with Mental Disorders: A Systematic Review. Front. Psychiatry 11, 445. 10.3389/fpsyt.2020.00445", "ArticleIdList": ["10.3389/fpsyt.2020.00445", "PMC7249851", "32508690"]}, {"Citation": "Cruz Da Silva E., Mercier M. C., Etienne-Selloum N., Dontenwill M., Choulier L. (2021). A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials. Cancers (Basel) 13 (8), 1795. 10.3390/cancers13081795", "ArticleIdList": ["10.3390/cancers13081795", "PMC8069979", "33918704"]}, {"Citation": "Dang Y., Lin G., Xie Y., Duan J., Ma P., Li G., et al. (2014). Quantitative Determination of Myricetin in Rat Plasma by Ultra Performance Liquid Chromatography Tandem Mass Spectrometry and its Absolute Bioavailability. Drug Res. (Stuttg) 64 (10), 516\u2013522. 10.1055/s-0033-1363220", "ArticleIdList": ["10.1055/s-0033-1363220", "24357136"]}, {"Citation": "Deng H., Liu S., Pan D., Jia Y., Ma Z. G. (2021). Myricetin Reduces Cytotoxicity by Suppressing Hepcidin Expression in MES23.5 Cells. Neural Regen. Res. 16 (6), 1105\u20131110. 10.4103/1673-5374.300461", "ArticleIdList": ["10.4103/1673-5374.300461", "PMC8224113", "33269757"]}, {"Citation": "Dhanraj V., Karuppaiah J., Balakrishnan R., Elangovan N. (2018). Myricetin Attenuates Neurodegeneration and Cognitive Impairment in Parkinsonism. Front. Biosci. (Elite Ed. 10, 481\u2013494. 10.2741/E835", "ArticleIdList": ["10.2741/E835", "29772521"]}, {"Citation": "Gupta G., Siddiqui M. A., Khan M. M., Ajmal M., Ahsan R., Rahaman M. A., et al. (2020). Current Pharmacological Trends on Myricetin. Drug Res. (Stuttg) 70 (10), 448\u2013454. 10.1055/a-1224-3625", "ArticleIdList": ["10.1055/a-1224-3625", "32877951"]}, {"Citation": "Hagenacker T., Hillebrand I., B\u00fcsselberg D., Sch\u00e4fers M. (2010). Myricetin Reduces Voltage Activated Potassium Channel Currents in DRG Neurons by a P38 Dependent Mechanism. Brain Res. Bull. 83 (5), 292\u2013296. 10.1016/j.brainresbull.2010.07.010", "ArticleIdList": ["10.1016/j.brainresbull.2010.07.010", "20655989"]}, {"Citation": "Hamdi H., Abid-Essefi S., Eyer J. (2021). Neuroprotective Effects of Myricetin on Epoxiconazole-Induced Toxicity in F98 Cells. Free Radic. Biol. Med. 164, 154\u2013163. 10.1016/j.freeradbiomed.2020.12.451", "ArticleIdList": ["10.1016/j.freeradbiomed.2020.12.451", "33429020"]}, {"Citation": "Hamed S. A. (2020). Cortical Excitability in Epilepsy and the Impact of Antiepileptic Drugs: Transcranial Magnetic Stimulation Applications. Expert Rev. Neurother. 20 (7), 707\u2013723. 10.1080/14737175.2020.1780122", "ArticleIdList": ["10.1080/14737175.2020.1780122", "32510285"]}, {"Citation": "Jang J. H., Lee S. H., Jung K., Yoo H., Park G. (2020). Inhibitory Effects of Myricetin on Lipopolysaccharide-Induced Neuroinflammation. Brain Sci. 10 (1), 32. 10.3390/brainsci10010032", "ArticleIdList": ["10.3390/brainsci10010032", "PMC7016734", "31935983"]}, {"Citation": "Joshi V., Mishra R., Upadhyay A., Amanullah A., Poluri K. M., Singh S., et al. (2019). Polyphenolic Flavonoid (Myricetin) Upregulated Proteasomal Degradation Mechanisms: Eliminates Neurodegenerative Proteins Aggregation. J. Cell. Physiol. 234 (11), 20900\u201320914. 10.1002/jcp.28695", "ArticleIdList": ["10.1002/jcp.28695", "31004355"]}, {"Citation": "Knekt P., Kumpulainen J., J\u00e4rvinen R., Rissanen H., Heli\u00f6vaara M., Reunanen A., et al. (2002). Flavonoid Intake and Risk of Chronic Diseases. Am. J. Clin. Nutr. 76 (3), 560\u2013568. 10.1093/ajcn/76.3.560", "ArticleIdList": ["10.1093/ajcn/76.3.560", "12198000"]}, {"Citation": "Kobayashi T., Mori Y. (1998). Ca2+ Channel Antagonists and Neuroprotection from Cerebral Ischemia. Eur. J. Pharmacol. 363 (1), 1\u201315. 10.1016/s0014-2999(98)00774-2", "ArticleIdList": ["10.1016/s0014-2999(98)00774-2", "9877076"]}, {"Citation": "Labb\u00e9 D., Proven\u00e7al M., Lamy S., Boivin D., Gingras D., B\u00e9liveau R. (2009). The Flavonols Quercetin, Kaempferol, and Myricetin Inhibit Hepatocyte Growth Factor-Induced Medulloblastoma Cell Migration. J. Nutr. 139 (4), 646\u2013652. 10.3945/jn.108.102616", "ArticleIdList": ["10.3945/jn.108.102616", "19244381"]}, {"Citation": "Lalitha N., Sadashivaiah B., Ramaprasad T. R., Singh S. A. (2020). Anti-hyperglycemic Activity of Myricetin, through Inhibition of DPP-4 and Enhanced GLP-1 Levels, Is Attenuated by Co-ingestion with Lectin-Rich Protein. PLoS One 15 (4), e0231543. 10.1371/journal.pone.0231543", "ArticleIdList": ["10.1371/journal.pone.0231543", "PMC7153899", "32282828"]}, {"Citation": "Lei Y., Chen J., Zhang W., Fu W., Wu G., Wei H., et al. (2012). In Vivo investigation on the Potential of Galangin, Kaempferol and Myricetin for protection of D-Galactose-Induced Cognitive Impairment. Food Chem. 135 (4), 2702\u20132707. 10.1016/j.foodchem.2012.07.043", "ArticleIdList": ["10.1016/j.foodchem.2012.07.043", "22980861"]}, {"Citation": "Li H. G., Chen J. X., Xiong J. H., Zhu J. W. (2021). Myricetin Exhibits Anti-glioma Potential by Inducing Mitochondrial-Mediated Apoptosis, Cell Cycle Arrest, Inhibition of Cell Migration and ROS Generation. J. BUON. 26 (1), 295.", "ArticleIdList": ["33721480"]}, {"Citation": "Li Y., Jiao Q., Xu H., Du X., Shi L., Jia F., et al. (2017). Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease. Front. Mol. Neurosci. 10, 339. 10.3389/fnmol.2017.00339", "ArticleIdList": ["10.3389/fnmol.2017.00339", "PMC5660707", "29114205"]}, {"Citation": "Li Z., Ferguson A. V. (1996). Electrophysiological Properties of Paraventricular Magnocellular Neurons in Rat Brain Slices: Modulation of IA by Angiotensin II. Neuroscience 71 (1), 133\u2013145. 10.1016/0306-4522(95)00434-3", "ArticleIdList": ["10.1016/0306-4522(95)00434-3", "8834397"]}, {"Citation": "Liu M., Guo H., Li Z., Zhang C., Zhang X., Cui Q., et al. (2020). Molecular Level Insight into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients with Alzheimer's Diseases. Front. Aging Neurosci. 12, 601603. 10.3389/fnagi.2020.601603", "ArticleIdList": ["10.3389/fnagi.2020.601603", "PMC7645199", "33192493"]}, {"Citation": "Ma Z., Liu T. (2012). Myricetin Facilitates Potassium Currents and Inhibits Neuronal Activity of PVN Neurons. Neurochem. Res. 37 (7), 1450\u20131456. 10.1007/s11064-012-0732-2", "ArticleIdList": ["10.1007/s11064-012-0732-2", "22382814"]}, {"Citation": "Ma Z., Wang G., Cui L., Wang Q. (2015). Myricetin Attenuates Depressant-like Behavior in Mice Subjected to Repeated Restraint Stress. Int. J. Mol. Sci. 16 (12), 28377\u201328385. 10.3390/ijms161226102", "ArticleIdList": ["10.3390/ijms161226102", "PMC4691049", "26633366"]}, {"Citation": "Ma Z. G., Wang J., Jiang H., Liu T. W., Xie J. X. (2007). Myricetin Reduces 6-Hydroxydopamine-Induced Dopamine Neuron Degeneration in Rats. Neuroreport 18 (11), 1181\u20131185. 10.1097/WNR.0b013e32821c51fe", "ArticleIdList": ["10.1097/WNR.0b013e32821c51fe", "17589323"]}, {"Citation": "McEwen B. S., Akil H. (2020). Revisiting the Stress Concept: Implications for Affective Disorders. J. Neurosci. 40 (1), 12\u201321. 10.1523/JNEUROSCI.0733-19.2019", "ArticleIdList": ["10.1523/JNEUROSCI.0733-19.2019", "PMC6939488", "31896560"]}, {"Citation": "Meyer J. H., Cervenka S., Kim M. J., Kreisl W. C., Henter I. D., Innis R. B. (2020). Neuroinflammation in Psychiatric Disorders: PET Imaging and Promising New Targets. Lancet Psychiatry 7 (12), 1064\u20131074. 10.1016/S2215-0366(20)30255-8", "ArticleIdList": ["10.1016/S2215-0366(20)30255-8", "PMC7893630", "33098761"]}, {"Citation": "Mishra A., Singh S., Tiwari V., Chaturvedi S., Wahajuddin M., Shukla S. (2019). Dopamine Receptor Activation Mitigates Mitochondrial Dysfunction and Oxidative Stress to Enhance Dopaminergic Neurogenesis in 6-OHDA Lesioned Rats: A Role of Wnt Signalling. Neurochem. Int. 129, 104463. 10.1016/j.neuint.2019.104463", "ArticleIdList": ["10.1016/j.neuint.2019.104463", "31078578"]}, {"Citation": "Molina-Jim\u00e9nez M. F., S\u00e1nchez-Reus M. I., Andres D., Cascales M., Benedi J. (2004). Neuroprotective Effect of Fraxetin and Myricetin against Rotenone-Induced Apoptosis in Neuroblastoma Cells. Brain Res. 1009 (1-2), 9\u201316. 10.1016/j.brainres.2004.02.065", "ArticleIdList": ["10.1016/j.brainres.2004.02.065", "15120578"]}, {"Citation": "Onvani S., Terakawa Y., Smith C., Northcott P., Taylor M., Rutka J. (2012). Molecular Genetic Analysis of the Hepatocyte Growth Factor/MET Signaling Pathway in Pediatric Medulloblastoma. Genes Chromosomes Cancer 51 (7), 675\u2013688. 10.1002/gcc.21954", "ArticleIdList": ["10.1002/gcc.21954", "22447520"]}, {"Citation": "Otto-Meyer S., DeFaccio R., Dussold C., Ladomersky E., Zhai L., Lauing K. L., et al. (2020). A Retrospective Survival Analysis of Glioblastoma Patients Treated with Selective Serotonin Reuptake Inhibitors. Brain Behav. Immun. Health 2, 100025. 10.1016/j.bbih.2019.100025", "ArticleIdList": ["10.1016/j.bbih.2019.100025", "PMC7079579", "32190845"]}, {"Citation": "Oueslati A., Paleologou K. E., Schneider B. L., Aebischer P., Lashuel H. A. (2012). Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human \u03b1-synuclein and Protects against its Toxicity in a Rat Model of Parkinson's Disease. J. Neurosci. 32 (5), 1536\u20131544. 10.1523/JNEUROSCI.3784-11.2012", "ArticleIdList": ["10.1523/JNEUROSCI.3784-11.2012", "PMC6703371", "22302797"]}, {"Citation": "Oyama Y., Fuchs P. A., Katayama N., Noda K. (1994). Myricetin and Quercetin, the Flavonoid Constituents of Ginkgo Biloba Extract, Greatly Reduce Oxidative Metabolism in Both Resting and Ca(2+)-Loaded Brain Neurons. Brain Res. 635 (1-2), 125\u2013129. 10.1016/0006-8993(94)91431-1", "ArticleIdList": ["10.1016/0006-8993(94)91431-1", "8173947"]}, {"Citation": "Piancone F., La Rosa F., Marventano I., Saresella M., Clerici M. (2021). The Role of the Inflammasome in Neurodegenerative Diseases. Molecules 26 (4), 953. 10.3390/molecules26040953", "ArticleIdList": ["10.3390/molecules26040953", "PMC7916884", "33670164"]}, {"Citation": "Pluta R., Januszewski S., Czuczwar S. J. (2021). Myricetin as a Promising Molecule for the Treatment of Post-Ischemic Brain Neurodegeneration. Nutrients 13 (2), 342. 10.3390/nu13020342", "ArticleIdList": ["10.3390/nu13020342", "PMC7911478", "33498897"]}, {"Citation": "Qiu Y., Cong N., Liang M., Wang Y., Wang J. (2017). Systems Pharmacology Dissection of the Protective Effect of Myricetin against Acute Ischemia/Reperfusion-Induced Myocardial Injury in Isolated Rat Heart. Cardiovasc. Toxicol. 17 (3), 277\u2013286. 10.1007/s12012-016-9382-y", "ArticleIdList": ["10.1007/s12012-016-9382-y", "27484498"]}, {"Citation": "Rahimi F. (2021). Alzheimer Disease: Controversies in Basic Science Research, Different Theories, and Reasons for Failed Trials. Biomedicines 9 (3), 254. 10.3390/biomedicines9030254", "ArticleIdList": ["10.3390/biomedicines9030254", "PMC7998475", "33807508"]}, {"Citation": "Raj K., Kaur P., Gupta G. D., Singh S. (2021). Metals Associated Neurodegeneration in Parkinson's Disease: Insight to Physiological, Pathological Mechanisms and Management. Neurosci. Lett. 753, 135873. 10.1016/j.neulet.2021.135873", "ArticleIdList": ["10.1016/j.neulet.2021.135873", "33812934"]}, {"Citation": "Ramezani M., Darbandi N., Khodagholi F., Hashemi A. (2016). Myricetin Protects Hippocampal CA3 Pyramidal Neurons and Improves Learning and Memory Impairments in Rats with Alzheimer's Disease. Neural Regen. Res. 11 (12), 1976\u20131980. 10.4103/1673-5374.197141", "ArticleIdList": ["10.4103/1673-5374.197141", "PMC5270437", "28197195"]}, {"Citation": "Satoh Y. (2021). The Potential of Hydrogen for Improving Mental Disorders. Curr. Pharm. Des. 27 (5), 695\u2013702. 10.2174/1381612826666201113095938", "ArticleIdList": ["10.2174/1381612826666201113095938", "33185151"]}, {"Citation": "Schr\u00f6der N., Figueiredo L. S., de Lima M. N. (2013). Role of Brain Iron Accumulation in Cognitive Dysfunction: Evidence from Animal Models and Human Studies. J. Alzheimers Dis. 34 (4), 797\u2013812. 10.3233/JAD-121996", "ArticleIdList": ["10.3233/JAD-121996", "23271321"]}, {"Citation": "Serra M., Pinna A., Costa G., Usiello A., Pasqualetti M., Avallone L., et al. (2021). Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease. Int. J. Mol. Sci. 22 (10), 5326. 10.3390/ijms22105326", "ArticleIdList": ["10.3390/ijms22105326", "PMC8158741", "34070217"]}, {"Citation": "Shimmyo Y., Kihara T., Akaike A., Niidome T., Sugimoto H. (2008). Multifunction of Myricetin on A Beta: Neuroprotection via a Conformational Change of A Beta and Reduction of A Beta via the Interference of Secretases. J. Neurosci. Res. 86 (2), 368\u2013377. 10.1002/jnr.21476", "ArticleIdList": ["10.1002/jnr.21476", "17722071"]}, {"Citation": "Shimmyo Y., Kihara T., Akaike A., Niidome T., Sugimoto H. (2008). Three Distinct Neuroprotective Functions of Myricetin against Glutamate-Induced Neuronal Cell Death: Involvement of Direct Inhibition of Caspase-3. J. Neurosci. Res. 86 (8), 1836\u20131845. 10.1002/jnr.21629", "ArticleIdList": ["10.1002/jnr.21629", "18265412"]}, {"Citation": "Siegelin M. D., Gaiser T., Habel A., Siegelin Y. (2009). Myricetin Sensitizes Malignant Glioma Cells to TRAIL-Mediated Apoptosis by Down-Regulation of the Short Isoform of FLIP and Bcl-2. Cancer Lett. 283 (2), 230\u2013238. 10.1016/j.canlet.2009.04.002", "ArticleIdList": ["10.1016/j.canlet.2009.04.002", "19398149"]}, {"Citation": "Sun L., Xu P., Fu T., Huang X., Song J., Chen M., et al. (2018). Myricetin against Ischemic Cerebral Injury in Rat Middle Cerebral Artery Occlusion Model. Mol. Med. Rep. 17 (2), 3274\u20133280. 10.3892/mmr.2017.8212", "ArticleIdList": ["10.3892/mmr.2017.8212", "29257250"]}, {"Citation": "Sun Z. Q., Meng F. H., Tu L. X., Sun L. (2019). Myricetin Attenuates the Severity of Seizures and Neuroapoptosis in Pentylenetetrazole Kindled Mice by Regulating the of BDNF-TrkB Signaling Pathway and Modulating Matrix Metalloproteinase-9 and GABAA. Exp. Ther. Med. 17 (4), 3083\u20133091. 10.3892/etm.2019.7282", "ArticleIdList": ["10.3892/etm.2019.7282", "PMC6425265", "30906480"]}, {"Citation": "Takeda H., Yamaguchi T., Yano H., Tanaka J. (2021). Microglial Metabolic Disturbances and Neuroinflammation in Cerebral Infarction. J. Pharmacol. Sci. 145 (1), 130\u2013139. 10.1016/j.jphs.2020.11.007", "ArticleIdList": ["10.1016/j.jphs.2020.11.007", "33357771"]}, {"Citation": "Tanaka M., V\u00e9csei L. (2020). Monitoring the Redox Status in Multiple Sclerosis. Biomedicines 8 (10), 406. 10.3390/biomedicines8100406", "ArticleIdList": ["10.3390/biomedicines8100406", "PMC7599550", "33053739"]}, {"Citation": "Tang N. P., Zhou B., Wang B., Yu R. B., Ma J. (2009). Flavonoids Intake and Risk of Lung Cancer: a Meta-Analysis. Jpn. J. Clin. Oncol. 39 (6), 352\u2013359. 10.1093/jjco/hyp028", "ArticleIdList": ["10.1093/jjco/hyp028", "19351659"]}, {"Citation": "van Ierssel S. H., Jorens P. G., Van Craenenbroeck E. M., Conraads V. M. (2014). The Endothelium, a Protagonist in the Pathophysiology of Critical Illness: Focus on Cellular Markers. Biomed. Res. Int. 2014, 985813. 10.1155/2014/985813", "ArticleIdList": ["10.1155/2014/985813", "PMC3988750", "24800259"]}, {"Citation": "Wang B., Zhong Y., Gao C., Li J. (2017). Myricetin Ameliorates Scopolamine-Induced Memory Impairment in Mice via Inhibiting Acetylcholinesterase and Down-Regulating Brain Iron. Biochem. Biophys. Res. Commun. 490 (2), 336\u2013342. 10.1016/j.bbrc.2017.06.045", "ArticleIdList": ["10.1016/j.bbrc.2017.06.045", "28619513"]}, {"Citation": "Wang Q. M., Wang G. L., Ma Z. G. (2016). Protective Effects of Myricetin on Chronic Stress-Induced Cognitive Deficits. Neuroreport 27 (9), 652\u2013658. 10.1097/WNR.0000000000000591", "ArticleIdList": ["10.1097/WNR.0000000000000591", "27171032"]}, {"Citation": "Wang X., Fang Y., Huang Q., Xu P., Lenahan C., Lu J., et al. (2021). An Updated Review of Autophagy in Ischemic Stroke: From Mechanisms to Therapies. Exp. Neurol. 340, 113684. 10.1016/j.expneurol.2021.113684", "ArticleIdList": ["10.1016/j.expneurol.2021.113684", "33676918"]}, {"Citation": "Wu S., Yue Y., Peng A., Zhang L., Xiang J., Cao X., et al. (2016). Myricetin Ameliorates Brain Injury and Neurological Deficits via Nrf2 Activation after Experimental Stroke in Middle-Aged Rats. Food Funct. 7 (6), 2624\u20132634. 10.1039/c6fo00419a", "ArticleIdList": ["10.1039/c6fo00419a", "27171848"]}, {"Citation": "Xiang D., Wang C. G., Wang W. Q., Shi C. Y., Xiong W., Wang M. D., et al. (2017). Gastrointestinal Stability of Dihydromyricetin, Myricetin, and Myricitrin: an In Vitro Investigation. Int. J. Food Sci. Nutr. 68 (6), 704\u2013711. 10.1080/09637486.2016.1276518", "ArticleIdList": ["10.1080/09637486.2016.1276518", "28114854"]}, {"Citation": "Xie Y., Wang Y., Xiang W., Wang Q., Cao Y. (2020). Molecular Mechanisms of the Action of Myricetin in Cancer. Mini. Rev. Med. Chem. 20 (2), 123\u2013133. 10.2174/1389557519666191018112756", "ArticleIdList": ["10.2174/1389557519666191018112756", "31648635"]}, {"Citation": "Zhang K., Ma Z., Wang J., Xie A., Xie J. (2011). Myricetin Attenuated MPP(+)-induced Cytotoxicity by Anti-oxidation and Inhibition of MKK4 and JNK Activation in MES23.5 Cells. Neuropharmacology 61 (1-2), 329\u2013335. 10.1016/j.neuropharm.2011.04.021", "ArticleIdList": ["10.1016/j.neuropharm.2011.04.021", "21549720"]}, {"Citation": "Zhang Q., Li Z., Wu S., Li X., Sang Y., Li J., et al. (2016). Myricetin Alleviates Cuprizone-Induced Behavioral Dysfunction and Demyelination in Mice by Nrf2 Pathway. Food Funct. 7 (10), 4332\u20134342. 10.1039/c6fo00825a", "ArticleIdList": ["10.1039/c6fo00825a", "27713953"]}, {"Citation": "Zhang S., Hu X., Guo S., Shi L., He Q., Zhang P., et al. (2019). Myricetin Ameliorated Ischemia/reperfusion-Induced Brain Endothelial Permeability by Improvement of eNOS Uncoupling and Activation eNOS/NO. J. Pharmacol. Sci. 140 (1), 62\u201372. 10.1016/j.jphs.2019.04.009", "ArticleIdList": ["10.1016/j.jphs.2019.04.009", "31130510"]}, {"Citation": "Zhang X. H., Ma Z. G., Rowlands D. K., Gou Y. L., Fok K. L., Wong H. Y., et al. (2012). Flavonoid Myricetin Modulates GABA(A) Receptor Activity through Activation of Ca(2+) Channels and CaMK-II Pathway. Evid. Based Complement. Alternat. Med. 2012, 758097. 10.1155/2012/758097", "ArticleIdList": ["10.1155/2012/758097", "PMC3520426", "23258999"]}, {"Citation": "Zhao H. F., Wang G., Wu C. P., Zhou X. M., Wang J., Chen Z. P., et al. (2018). A Multi-Targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility. CNS Neurol. Disord. Drug Targets 17 (7), 557\u2013567. 10.2174/1871527317666180611090006", "ArticleIdList": ["10.2174/1871527317666180611090006", "29886836"]}, {"Citation": "Zhu X., Jia Y. H. (2014). Inhibition of Catechol-O-Methyltransferase (COMT) by Myricetin, Dihydromyricetin, and Myricitrin. Pharmazie 69 (3), 183\u2013186.", "ArticleIdList": ["24716406"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "18"}, {"Year": "2021", "Month": "11", "Day": "29"}, {"Year": "2022", "Month": "1", "Day": "3", "Hour": "5", "Minute": "36"}, {"Year": "2022", "Month": "1", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "4", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "12", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["34975495", "PMC8716845", "10.3389/fphar.2021.797298", "797298"]}}], "PubmedBookArticle": []}